Search research articles
Contact Us
Filters
Showing results (21-30 of 105) with videos related to
Page
of 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 28, 2013
Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer
Michael E Werner, Natalie D Cummings, Manish Sethi, et al.
Journal of Virology
|
February 24, 2012
Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model
Kathy H Y Shair, Katharine M Bendt, Rachel H Edwards, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2005
Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies
Don A Gabriel, Thomas C Shea, Jonathan S Serody, et al.
Analytical Chemistry
|
November 3, 2016
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
Qi Yang, Timothy M Jacobs, Justin D McCallen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history
Bert H O'Neil, Robert Allen, David R Spigel, et al.
Leukemia & Lymphoma
|
August 5, 2011
A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma
Anne W Beaven, Thomas C Shea, Dominic T Moore, et al.
Gastrointestinal Cancer Research : GCR
|
November 2, 2011
Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma
Hanna K Sanoff, Stephen Bernard, Richard M Goldberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 2, 2008
Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies
Thomas E Stinchcombe, Mark A Socinski, Carrie B Lee, et al.
BJU International
|
March 5, 2014
Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies
Bryce B Reeve, Ronald C Chen, Dominic T Moore, et al.
Cancer
|
January 31, 2013
Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria
Noam A Vanderwalde, Ellen L Jones, Randall J Kimple, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 105) with videos related to
Sort By:
Page
of 11
International Journal of Radiation Oncology, Biology, Physics
|
May 28, 2013
Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer
Michael E Werner, Natalie D Cummings, Manish Sethi, et al.
Journal of Virology
|
February 24, 2012
Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model
Kathy H Y Shair, Katharine M Bendt, Rachel H Edwards, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2005
Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies
Don A Gabriel, Thomas C Shea, Jonathan S Serody, et al.
Analytical Chemistry
|
November 3, 2016
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
Qi Yang, Timothy M Jacobs, Justin D McCallen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history
Bert H O'Neil, Robert Allen, David R Spigel, et al.
Leukemia & Lymphoma
|
August 5, 2011
A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma
Anne W Beaven, Thomas C Shea, Dominic T Moore, et al.
Gastrointestinal Cancer Research : GCR
|
November 2, 2011
Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma
Hanna K Sanoff, Stephen Bernard, Richard M Goldberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 2, 2008
Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies
Thomas E Stinchcombe, Mark A Socinski, Carrie B Lee, et al.
BJU International
|
March 5, 2014
Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies
Bryce B Reeve, Ronald C Chen, Dominic T Moore, et al.
Cancer
|
January 31, 2013
Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria
Noam A Vanderwalde, Ellen L Jones, Randall J Kimple, et al.
Page
of 11